| Durvalumab investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 280show all (up to 200) |
|---|
| → investigated in trials for | Lung Non-Small Cell Carcinomasubtype 142 trials (53 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Non-Small Cell Carcinoma | 142 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lung Small Cell Carcinomasubtype 52 trials (35 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Small Cell Carcinoma | 52 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hepatocellular Carcinomasubtype 51 trials (37 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Hepatocellular Carcinoma | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Lung Neoplasm 42 trials (22 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Lung Neoplasm | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Breast Neoplasm 29 trials (13 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Breast Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Solid Neoplasm 26 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Solid Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Biliary Tract Neoplasmsubtype 24 trials (18 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Biliary Tract Neoplasm | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Colorectal Neoplasmsubtype 23 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Colorectal Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Pancreatic Neoplasm 20 trials (8 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Pancreatic Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Bladder Neoplasmcancer 19 trials (9 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Bladder Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Head and Neck Squamous Cell Carcinomasubtype 18 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Head and Neck Squamous Cell Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Neoplasm 18 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Intrahepatic Cholangiocarcinoma 16 trials (11 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Intrahepatic Cholangiocarcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Ovarian Neoplasm 13 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Ovarian Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Triple-Negative Breast Carcinoma 13 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Triple-Negative Breast Carcinoma | 13 | Observed | clinicaltrials | graph → |